MALVERN, Pa., May 18, 2023 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today…
Source: www.marketscreener.com – Read more
Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer
Must Read
AIIMS Hospital Targeted: Cyber Attack Strikes India’s Premier Medical Institution
NEW DELHI: Delhi’s All India Institute of Medical Sciences (AIIMS), known as one of India’s premier government hospitals, faced a potential cyber attack on...
